JONATHAN CAMPBELL: Open Payments
NPI 1821065509 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 31 payments from 7 companies in 2025. Trend: 2023 $160 · 2024 $142 · 2025 $426
Food & beverage: $394Education: $32
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $219 |
| SANOFI-AVENTIS U.S. LLC | 2 | $47 |
| Lilly USA, LLC | 3 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Indivior Inc. | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: Ozempic, Rybelsus, TZIELD, MOUNJARO, Kerendia, SUBLOCADE, FARXIGA, TRELEGY ELLIPTA.
Industry payments across AL — which companies pay providers there.
